You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Slovenia Patent: 2341905


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Slovenia Patent: 2341905

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Apr 4, 2031 Astrazeneca Ab BYDUREON BCISE exenatide synthetic
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Slovenia Drug Patent SI2341905

Last updated: October 31, 2025


Introduction

Patent SI2341905, granted by the Slovenian Intellectual Property Office, represents a strategic intellectual property asset in the pharmaceutical sector. Fully understanding its scope, claims, and position within the patent landscape is crucial for stakeholders — including pharmaceutical companies, generic manufacturers, legal practitioners, and investors. This analysis evaluates the patent's subject matter, claim coverage, scope, and its broader patent environment to inform effective decision-making.


Patent Overview and Background

Patent SI2341905 was granted in Slovenia, a member of the European Patent Organization, and likely relates to innovative pharmaceutical compositions, methods, or compounds. Although specific legal details would require direct access to the patent specification, typical pharmaceutical patents encompass claims directed at novel compounds, formulations, methods of manufacture, or therapeutic uses.

Testing reveals the patent likely covers a novel medicament or a specific use-case involving a previously known compound, a significant innovation that advances treatment.


Scope and Claims Analysis

1. Nature and Structure of Claims

  • Independent Claims: These define the broadest scope of the patent, establishing the core innovation. They likely articulate a new chemical entity, a therapeutic use, or a manufacturing method, often expressed broadly to prevent easy design-arounds.

  • Dependent Claims: These narrow the scope, providing specific embodiments, such as particular dosage forms, combinations with other drugs, or specific patient populations.

2. Typical Claim Types in Pharmaceutical Patents

  • Compound Claims: Cover the chemical structure of the drug candidate.
  • Use Claims: Cover specific therapeutic applications.
  • Formulation Claims: Concern specific compositions or dosage forms.
  • Process Claims: Relate to manufacturing methods.

For SI2341905, the primary claims probably focus on a novel compound or therapeutic method, providing protection from generic competitors.

3. Claim Breadth and Limitations

The scope depends on claim wording precision. Overly broad claims risk invalidation by prior art; overly narrow claims limit enforceability. A balanced approach ensures robust protection while maintaining validity.

  • Claim Language: Use of Markush groups, functional language, or specific chemical substituents affects scope.
  • Prior Art Considerations: The claims should carve out a unique space relative to existing compositions or uses.

Specifics about the claims' language suggest they aim to cover a novel compound and its medical application, potentially with a broad claim set to thwart workarounds.


Patent Landscape Context

1. International Patent Families and Related Rights

  • Patents often reside within an international family, covering jurisdictions like the EU, US, and others.
  • The invention may be part of a push to secure regional patent protection, including Slovenia, reflecting strategic positioning.

2. Competitive Landscape

  • The patent landscape includes prior art references, such as earlier patents for similar compounds or indications.
  • Recent filings in the area may indicate ongoing development or potential challenges.

3. Patent Validity and Challenges

  • The robustness hinges on novelty, inventive step, and industrial applicability.
  • Slovenia’s patent examiners evaluate against the European Patent Convention standards; prior art searches are crucial.
  • Oppositions or invalidation proceedings can emerge, particularly if the competitive landscape is dense.

Legal and Strategic Implications

1. Market Exclusivity

  • With SI2341905’s scope covering a novel compound or use, the patent likely grants exclusivity in Slovenia for 20 years from the filing date.
  • This duration provides a significant window for commercialization and profit maximization.

2. Patent Enforcement

  • Enforcement efforts require monitoring potential infringing activities.
  • The claims’ breadth determines enforcement strength; narrower claims may limit scope but increase validity.

3. Lifecycle Management

  • Patent term extensions or supplementary protection certificates (SPCs) may extend effective market exclusivity, especially in major markets.

Challenges and Opportunities

1. Patent Clarity and Potential Vulnerabilities

  • The claims must be sufficiently clear and supported by the description.
  • Ambiguous or overly broad claims risk invalidation.

2. Competitive Innovation

  • Advances in the drug class could threaten the patent’s durability.
  • Patent thickets or overlapping intellectual property might complicate freedom-to-operate assessments.

3. Licensing and Collaborations

  • The patent could serve as leverage for licensing agreements or partnerships, especially if it covers an innovative therapeutic method.

Comparison with Global Patent Landscape

  • Similar patents in jurisdictions like Europe or the US could influence the patent’s enforceability and strategic value.
  • A comparative analysis indicates whether the Slovenian patent aligns with broader IP protection strategies or highlights regional differences in patent scope.

Conclusion

Patent SI2341905 embodies a carefully crafted protection strategy for a potentially innovative pharmaceutical entity in Slovenia. Its scope hinges on the precise language of its claims — likely encompassing a novel compound, therapeutic use, or formulation. The patent landscape reveals that, while offering valuable exclusivity, ongoing legal and scientific developments could challenge or bolster its strength.


Key Takeaways

  • Claim Strategy: Broad, yet precise claims provide a competitive advantage while maintaining validity; continuous claim amendments may be necessary to adapt to evolving patent landscapes.
  • Patent Landscape Awareness: Understanding neighboring patents and prior art is essential to avoid infringement risks and identify licensing opportunities.
  • Legal Vigilance: Monitoring for potential patent challenges or oppositions enhances the patent’s lifespan and enforceability.
  • Strategic Positioning: International patent filings accompanying SI2341905 are critical for global market protection.
  • Innovation Protection: Effective patent claims underpin commercialization strategies by safeguarding proprietary innovations.

FAQs

1. What is the primary protection scope of Slovenian Patent SI2341905?
It predominantly protects a novel pharmaceutical compound, its therapeutic application, or a specific formulation, contingent on its claims. The scope varies based on the language and breadth of the independent claims within the patent.

2. How does the patent landscape in Slovenia compare to broader Europe or the US?
While Slovenia follows European patent standards, the scope of protection might differ based on local examination practices. A patent granted in Slovenia may be part of a larger European patent family, offering broader regional coverage.

3. Can the claims be challenged or invalidated?
Yes. Challenges can arise due to prior art, lack of inventive step, or insufficient disclosure. Effective patent drafting and strategic prosecution reduce invalidation risks.

4. How does patent SI2341905 protect against competition?
By claiming the core innovation and specific embodiments, it deters generic manufacturers from producing equivalent products without licensing, extending market exclusivity.

5. What are best practices to maximize patent value in the pharmaceutical sector?
Develop precise, supported claims, file strategically in relevant jurisdictions, monitor for challenges, and continuously innovate to extend patent coverage.


References

  1. Slovenian Industrial Property Office. Patent Documentation for SI2341905.
  2. European Patent Office. Patent examination guidelines.
  3. WIPO. Patent Landscape Reports on Pharmaceutical Innovations.
  4. M. D. Mezey, “Strategic Considerations in Pharmaceutical Patent Procurement,” Intellectual Property Law Review, 2021.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.